Scott Giatpaiboon
About Scott Giatpaiboon
Scott Giatpaiboon is a Research Associate at Synedgen, Inc, specializing in glycomics research to improve health outcomes in humans and animals. He has a background in Biochemistry and Chemistry from UC Santa Barbara and has focused on developing therapies that target the glycocalyx to manage inflammation and bacterial interactions.
Work at Synedgen
Scott Giatpaiboon has been a Research Associate at Synedgen, Inc. since 2015. His role involves conducting glycomics research to tackle complex health issues affecting both human and animal health. He focuses on designing polysaccharide-based molecules that aim to reduce biofilm viscosity and cohesion. This work is significant in enhancing the efficacy of antibiotics, contributing to the development of innovative therapies.
Education and Expertise
Scott Giatpaiboon earned a Bachelor’s degree in Biochemistry and Chemistry from the University of California, Santa Barbara, completing his studies from 2011 to 2015. His academic background provides a strong foundation for his research in glycomics, where he applies his knowledge to develop therapies that target the glycocalyx, addressing issues related to inflammation and bacterial interactions.
Background
Scott Giatpaiboon has a background in biochemistry and chemistry, which he studied at UC Santa Barbara. His educational journey laid the groundwork for his current research endeavors. Since joining Synedgen, Inc., he has focused on the intersection of glycomics and health, contributing to advancements in therapeutic approaches.
Research Focus
Scott Giatpaiboon engages in glycomics research aimed at addressing complex health challenges. His work includes the development of therapies that specifically target the glycocalyx, which plays a crucial role in controlling inflammation and bacterial interactions. This research is vital for improving health outcomes in both human and animal populations.